The 2012 Conference Programme For AIDS

The International Symposium on HIV and Emerging Infectious Diseases (ISHEID) Congress has released its preliminary programme for the upcoming 2012 Symposium, being held in Marseille, France, May 23-25, 2012.

Neuilly-sur-Seine, France, May 21, 2011 -- Exceptional health professionals and research scientists in the field will speak during the three-day conference, discussing their latest research and touching base with colleagues. The life of an HIV-infected person has improved over the years; but more work is needed. After all, a cure for HIV hasn't been found, and that is the ultimate goal of all research on the subject. Advances in medication and treatment have lengthened the life expectancy for an HIV-positive person. The number of anti-HIV medicines on the market has increased substantially.

HIV is not the immediate death sentence it may have been 25 years ago. While being diagnosed with HIV is certainly a life-changing experience, people have become more pragmatic about it than they were a generation ago. With the effective treatment available now, HIV can become not much more than a chronic health condition that must be managed, not unlike asthma or diabetes. It isn't as devastating as it once was. There are people alive today who have lived with HIV for 15, 20, or 25 years or more.

That being said, the international community must improve access to HIV treatments. There are certain countries in the world where it is very difficult to gain access to antiretroviral medications, especially countries in south Asia and sub-Saharan Africa. Prevention from spreading HIV needs to be a top priority in these countries, and prophylaxis isn't widely available either, which exacerbates the problem. Once people become infected with HIV, a significant number of them are waiting far too long to see their doctor for diagnosis, allowing the disease to progress to such an advanced stage where the probability for survival has decreased.

Experienced leaders at this conference will be speaking on a variety of issues, and this is reflected in the programme. In fact, the very first plenary session talks about HIV prevention. The first day of the symposium is mostly about attacking the disease and the therapy available to help people manage their HIV, while the second day concentrates on how the disease proliferates and how a cure can possibly be found. The third and final day of the symposium wraps things up by continuing the talk about antiretroviral therapy and a discussion on other emerging infectious diseases. The HIV research community invites those who wish to attend the ISHEID Congress Symposium to hear the latest on worldwide HIV treatments.

The HIV research community invites those who wish to attend the ISHEID Congress Symposium to hear the latest on worldwide HIV treatments.

Contact:
Alain Lafeuillade
Overcome ISHEID
Blvd Paul Emile Victor
92523 Neuilly-sur-Seine, France
+33-1-41920120
isheid@overcome.fr
http://www.isheid.com

This release was published on openPR.